The biotechnology company's potential COVID-19 treatment quickened recovery time in a study. NXP Semiconductors N.V., up $6.70 to $141.53.
News
- NXP, Matson rise; Advanced Micro Devices, Mallinckrodt fall
- Recognizing World Mental Health | Inspired New Musical Score to Debut This Month
... world renowned Me2/Orchestra and Neurocrine Biosciences will launch the charitable initiative and community platform, Monumental Moments™.
- Antibody drugs are no cure but seem promising for COVID-19
Amgen, Adaptive Biotechnologies and the Singapore biotech company Tychan Pte Ltd. also have studies underway. Q: When might they be available?
- Sentien Biotechnologies-Led Team Awarded $2.4M Contract from the US Department of Defense ...
Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... GenCure, a subsidiary of San Antonio-based nonprofit BioBridge Global, ...
- Meet the Queens-bred billionaires behind COVID drug-maker Regeneron
The biotech company President Trump credited with helping him fend off the coronavirus is run by two Queens-bred billionaires who still have roots in ...